Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01662115
Other study ID # CRS-2012-05
Secondary ID
Status Terminated
Phase Phase 4
First received August 7, 2012
Last updated August 21, 2017
Start date August 2012
Est. completion date June 2014

Study information

Verified date August 2017
Source The Cleveland Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate whether the use of nicotine gum in the postoperative period influences surgical outcome in patients undergoing colorectal surgery.


Description:

The main hypothesis of this study is that use of nicotine gum after colorectal surgery will accelerate recovery of bowel function. Eligible patients include all patients undergoing segmental small bowel or large bowel resection with a planned primary anastomosis, planned removal of the nasogastric tube at the end of the surgery, and administration of clear liquids on post-operative day one. Patients who have an ileostomy or colostomy created will be excluded. Patients enrolled in the study will be randomized to one of three groups: nicotine gum, regular gum, or no gum. Patients randomized to nicotine gum or regular gum will chew the gum three times a day for 1 week. The main outcome measure is time to first bowel movement or flatus.


Recruitment information / eligibility

Status Terminated
Enrollment 4
Est. completion date June 2014
Est. primary completion date June 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- Able to freely give written informed consent to participate in the study and have signed the Informed Consent Form;

- Due to undergo small and/or large partial bowel resection via laparotomy or laparoscopy;

Exclusion Criteria:

- Prior intestinal surgery

- Mentally incompetent or unable or unwilling to provide informed consent or comply with study procedures

- American Society of Anesthesiologists (ASA) Class IV or V;

- History of abdominal carcinomatosis;

- History of radiation enteritis;

- Children < 18 or adults > 85 years of age

- Pregnant women

- Current cigarette, cigar smokers and chewers of tobacco. ex smokers who quit less than 3 months ago.

- Patients requiring postoperative ventilation, pressor requirement or ICU stay

- Patients with prior cardiovascular disorders

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Nicotine gum
Patients will chew nicotine gum 3 times a day until discharge or 7 days, whichever comes first
Other:
Regular chewing gum
Patients will chew regular sugar-free gum 3 times a day until discharge or 7 days, whichever comes first

Locations

Country Name City State
United States Cleveland Clinic Florida Weston Florida

Sponsors (1)

Lead Sponsor Collaborator
The Cleveland Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Bowel Function Recovery Time to first bowel movement or flatus 7 days
Secondary Hospital Stay Length of postoperative hospital stay 30 days
Secondary Post-operative Vomiting Episodes of vomiting 30 days
Secondary Use of NG Tubes Nasogastric tube (re)insertions 30 days
See also
  Status Clinical Trial Phase
Terminated NCT00443040 - Asimadoline for the Treatment of Post-Operative Ileus Phase 2
Recruiting NCT02673671 - G-Tech Feasibility Study for Early Detection of a Post-op Ileus
Completed NCT01869231 - Evaluating the Efficacy of Current Treatments for Reducing Postoperative Ileus N/A
Recruiting NCT04009954 - Post-operative Ileus and Gut Microbiota